Home›Companies›Biotech & Pharma›Aakha Biologics

Aakha Biologics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 17, 2024·Suggest an edit

About Aakha Biologics

Aakha Biologics is a private company based in Frisco, Texas, incorporated in 2022 in Delaware. It has reported $750,000 raised in one offering on Form D since July 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 2, 2024Jul 17, 2024$750,000of $5.0M target1$750KDebt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aakha Biologics's Form D filed Jul 17, 2024.

HB
Hemanta Baruah
President and director
Errik Anderson
Errik Anderson
Director
Also a founder, CEO, chairman of alloy at Alloy Therapeutics and a director at Angiex.

Sources

  1. SECAakha Biologics, Inc. filing history